Vyant Bio, Inc.
DelistedCIK 1349929fmd_10S180ZT7N38WF1A91QB5QH1YWServices · Services-Medical LaboratoriesTemplate: Standard
Coverage: Jan 01, 2011 to Dec 31, 2022, 45 periods
Latest annual · FY2022
Millions- Total revenues
- 1
- Gross profit
- 2
- Operating income
- (16)
- Net income
- (23)
- Free cash flow
- (14)
Latest quarter · Q4 FY2022
Millions- Total revenues
- 0
- Operating income
- (3)
- Net income
- (4)
- Free cash flow
- (3)
Key stats
Open AnalysisCompound annual growth
- Revenue, 3 yearsFY2019 to FY2022
- -55.0%
- Revenue, 5 yearsFY2017 to FY2022
- -53.0%
- Net income, 5 yearsFY2017 to FY2022
- n/m
Vyant Bio, Inc. financials: quick answers
Annual figures as filed with the SEC. Each number links to the filing it came from and to its proof.
| Metric | FY2022 | FY2021 | Change | Source |
|---|---|---|---|---|
| Revenue | $666,000 | $1.1 million | -42% | 10-K 2023-03-31 · proof |
| Operating income | -$15.9 million | -$15.7 million | 10-K 2023-03-31 · proof | |
| Net income | -$22.7 million | -$40.9 million | 10-K 2023-03-31 · proof | |
| Cash from operating activities | -$13.7 million | -$17 million | 10-K 2023-03-31 · proof | |
| Free cash flow | -$14.3 million | -$17.5 million | 10-K 2023-03-31 · proof | |
| Total assets | $15.2 million | $37.6 million | -59.6% | 10-K 2023-03-31 · proof |
| Total liabilities | $5.3 million | $6.3 million | -16.5% | 10-K 2023-03-31 · proof |
| Cash and cash equivalents | $10 million | $20.6 million | -51.3% | 10-K 2023-03-31 · proof |
- What was Vyant Bio, Inc.'s revenue in fiscal 2022?
- Vyant Bio, Inc. reported revenue of $666,000 for fiscal 2022 (the year ended Dec 31, 2022), against $1.1 million the year before (-42%). Source: the 10-K filed with the SEC on Mar 31, 2023. SEC
- What was Vyant Bio, Inc.'s operating income in fiscal 2022?
- Vyant Bio, Inc. reported operating income of -$15.9 million for fiscal 2022 (the year ended Dec 31, 2022), against -$15.7 million the year before. Source: the 10-K filed with the SEC on Mar 31, 2023. SEC
- What was Vyant Bio, Inc.'s net income in fiscal 2022?
- Vyant Bio, Inc. reported net income of -$22.7 million for fiscal 2022 (the year ended Dec 31, 2022), against -$40.9 million the year before. Source: the 10-K filed with the SEC on Mar 31, 2023. SEC
- What was Vyant Bio, Inc.'s cash from operating activities in fiscal 2022?
- Vyant Bio, Inc. reported cash from operating activities of -$13.7 million for fiscal 2022 (the year ended Dec 31, 2022), against -$17 million the year before. Source: the 10-K filed with the SEC on Mar 31, 2023. SEC
- What was Vyant Bio, Inc.'s free cash flow in fiscal 2022?
- Vyant Bio, Inc. reported free cash flow of -$14.3 million for fiscal 2022 (the year ended Dec 31, 2022), against -$17.5 million the year before. Source: the 10-K filed with the SEC on Mar 31, 2023. SEC
- What are Vyant Bio, Inc.'s total assets?
- As of Dec 31, 2022, Vyant Bio, Inc. reported total assets of $15.2 million, against $37.6 million a year earlier (-59.6%). Source: the 10-K filed with the SEC on Mar 31, 2023. SEC
- What are Vyant Bio, Inc.'s total liabilities?
- As of Dec 31, 2022, Vyant Bio, Inc. reported total liabilities of $5.3 million, against $6.3 million a year earlier (-16.5%). Source: the 10-K filed with the SEC on Mar 31, 2023. SEC
- What are Vyant Bio, Inc.'s cash and cash equivalents?
- As of Dec 31, 2022, Vyant Bio, Inc. reported cash and cash equivalents of $10 million, against $20.6 million a year earlier (-51.3%). Source: the 10-K filed with the SEC on Mar 31, 2023. SEC
Read from the FinancialMD API on Nov 14, 2026. Values change only when a new filing is made; see the Financials tab for every period and as-of replay.
The same numbers for an agent, with proof on every value:
curl "https://api.financial.md/v1/company/financials/income_statement/standardized?company=cik:1349929&period_type=annual&limit=5"Information only, not investment advice.